We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+11.77%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$5.8B
AUM Growth
-$40.1M
Cap. Flow
-$460M
Cap. Flow %
-7.92%
Top 10 Hldgs %
24.55%
Holding
197
New
37
Increased
72
Reduced
55
Closed
17

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$46.7M
2
IRTC icon
iRhythm Holdings
IRTC
+$37M
3
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$35.8M
4
ENTG icon
Entegris
ENTG
+$21.4M
5
GLBE icon
Global E Online
GLBE
+$20.4M

Top Sells

Rank Stock Value
1
TMDX icon
Transmedics
TMDX
+$70.1M
2
TT icon
Trane Technologies
TT
+$69.4M
3
DDOG icon
Datadog
DDOG
+$63.8M
4
ARGX icon
argenx
ARGX
+$56M
5
GTLB icon
GitLab
GTLB
+$46.9M

Sector Composition

Rank Sector Weight
1 Healthcare 40.6%
2 Technology 18.78%
3 Industrials 17.39%
4 Consumer Discretionary 9.97%
5 Financials 2.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TT icon
1
Trane Technologies
TT
$97.3B
$235M 4.06%
605,407
-200,095
-25% -$69.4M
DHI icon
2
D.R. Horton
DHI
$40.7B
$161M 2.78%
845,561
+12,013
+1% +$2.11M
ODFL icon
3
Old Dominion Freight Line
ODFL
$44.2B
$149M 2.56%
748,495
-3,631
-0.5% -$706K
ROP icon
4
Roper Technologies
ROP
$38.5B
$145M 2.5%
260,445
+9,887
+4% +$5.44M
WCN
5
Waste Connections
WCN
$41.9B
$144M 2.49%
807,637
+548
+0.1% +$99.2K
MIRM icon
6
Mirum Pharmaceuticals
MIRM
$6.87B
$134M 2.32%
3,445,363
-169,457
-5% -$6.76M
MTD icon
7
Mettler-Toledo International
MTD
$27.9B
$119M 2.05%
79,129
+5,504
+7% +$7.73M
TTD icon
8
Trade Desk
TTD
$8.59B
$115M 1.98%
1,047,149
-256,266
-20% -$25.6M
CLDX icon
9
Celldex Therapeutics
CLDX
$3.02B
$113M 1.95%
3,332,005
+4,873
+0.1% +$186K
TMDX icon
10
Transmedics
TMDX
$2.63B
$108M 1.87%
690,632
-454,798
-40% -$70.1M
EVH icon
11
Evolent Health
EVH
$358M
$108M 1.85%
3,804,104
+64,985
+2% +$1.67M
COLL icon
12
Collegium Pharmaceutical
COLL
$1.17B
$102M 1.76%
2,635,406
+750
+0% +$26.7K
IDXX icon
13
Idexx Laboratories
IDXX
$44.1B
$95.2M 1.64%
188,412
+88
+0% +$42.8K
GH icon
14
Guardant Health
GH
$20.2B
$88M 1.52%
3,837,300
+76,762
+2% +$2.17M
ROL icon
15
Rollins
ROL
$18.5B
$88M 1.52%
1,739,892
+34,746
+2% +$1.72M
MPWR icon
16
Monolithic Power Systems
MPWR
$64.7B
$86.8M 1.5%
93,869
-4,734
-5% -$4.09M
MNDY icon
17
monday.com
MNDY
$3.73B
$84.7M 1.46%
305,035
-13,882
-4% -$3.44M
EXAS
18
DELISTED
Exact Sciences
EXAS
$83.9M 1.45%
1,232,119
+391
+0% +$22.1K
XMTR icon
19
Xometry
XMTR
$4.69B
$81.2M 1.4%
4,418,664
-1,601,903
-27% -$26.3M
VST icon
20
Vistra
VST
$50.1B
$80.2M 1.38%
676,388
+182,585
+37% +$15.5M
LOW icon
21
Lowe's Companies
LOW
$118B
$74.9M 1.29%
276,364
+3,252
+1% +$788K
AXSM icon
22
Axsome Therapeutics
AXSM
$12.1B
$74.4M 1.28%
827,887
-110,827
-12% -$9.67M
LRCX icon
23
Lam Research
LRCX
$372B
$71.4M 1.23%
875,450
-134,180
-13% -$11.7M
TOST icon
24
Toast
TOST
$19.1B
$70.7M 1.22%
2,497,164
-738,315
-23% -$18.7M
VRNA
25
DELISTED
Verona Pharma
VRNA
$69.8M 1.2%
2,425,846
+1,898,065
+360% +$46.7M
1
2 3 4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q3 2024 Portfolio in Review

As of Q3 2024, Eventide Asset Management held 197 positions worth $5.8B, down 0.69% from $5.84B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Eventide Asset Management withdrew a net $460M in Q3 2024, closing 17 positions and reducing 55 holdings. Its most notable exit was Nextpower Inc, an estimated $36.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 38% a quarter earlier, followed by Technology and Industrials.

Against the trend, Eventide Asset Management opened a new position in Relay Therapeutics worth $19M.

  • Eventide Asset Management's largest Q3 2024 buy was Relay Therapeutics: 2,682,083 shares worth $19M.
  • Eventide Asset Management added most to Verona Pharma in Q3 2024, an estimated $46.7M increase.
  • Eventide Asset Management's biggest Q3 2024 reduction was Transmedics, cutting an estimated $70.1M.
  • Eventide Asset Management fully exited Nextpower Inc in Q3 2024, selling an estimated $36.6M.
  • Eventide Asset Management's ten largest holdings make up 25% of its $5.8B portfolio in Q3 2024.
  • Eventide Asset Management opened 37 new positions and closed 17 in Q3 2024.
  • Eventide Asset Management's portfolio value fell 0.69% quarter-over-quarter to $5.8B.

Based on Eventide Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.